Committee for Advanced Therapies (CAT)

GPTKB entity

Statements (51)
Predicate Object
gptkbp:instanceOf scientific committee
gptkbp:advises on regulatory processes
gptkbp:aimsTo ensure patient safety
gptkbp:collaboratesWith other regulatory bodies
gptkbp:composedOf experts in various fields
gptkbp:contributedTo regulatory framework for advanced therapies
gptkbp:establishedIn 2009
gptkbp:evaluates clinical trial data
safety and efficacy of therapies
gptkbp:facilitates stakeholder engagement
gptkbp:focusesOn advanced therapy medicinal products
gptkbp:hasMember scientists
clinicians
patient representatives
regulatory experts
https://www.w3.org/2000/01/rdf-schema#label Committee for Advanced Therapies (CAT)
gptkbp:isAvenueFor gptkb:European_Medicines_Agency's_Committee_for_Human_Medicinal_Products
gptkbp:isFundedBy gptkb:European_Union
gptkbp:isInvolvedIn training programs
policy advocacy
public health initiatives
international collaborations
safety monitoring
scientific conferences
scientific assessments
research funding decisions
data sharing initiatives
clinical guidelines development
stakeholder workshops
regulatory science initiatives
patient safety assessments
product development discussions
risk-benefit evaluations
therapeutic area evaluations
gptkbp:isLocatedIn gptkb:Amsterdam
gptkbp:isResponsibleFor guiding advanced therapy regulations
gptkbp:issues guidelines
gptkbp:meets regularly
working groups
gptkbp:monitors emerging therapies
gptkbp:participatesIn public consultations
gptkbp:partOf gptkb:European_Medicines_Agency
gptkbp:provides scientific advice
training for assessors
input on policy development
recommendations for product classification
gptkbp:publishes scientific opinions
gptkbp:reviews scientific literature
marketing authorization applications
gptkbp:supports innovation in healthcare
gptkbp:worksWith gptkb:European_Commission